CHERYL WETZKER: Open Payments
NPI 1417725300 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 68 payments from 16 companies in 2025. Trend: 2023 $77 · 2024 $1,153 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $260 |
| Amgen Inc. | 16 | $192 |
| Otsuka America Pharmaceutical, Inc. | 5 | $130 |
| Novo Nordisk Inc | 5 | $115 |
| Janssen Pharmaceuticals, Inc | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Lilly USA, LLC | 4 | $92 |
| GlaxoSmithKline, LLC. | 3 | $90 |
| BETA BIONICS, INC. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
Products named: OTEZLA, QULIPTA, REXULTI, UBRELVY, SPRAVATO, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO.
Industry payments across IL — which companies pay providers there.
